Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pablo, Pérez Huertas"'
Autor:
Mayte Gil-Candel, Antonio Solana-Altabella, Esther Vicente-Escrig, Aarón Puplá-Bartoll, Julia Bodega Azuara, Pablo Pérez-Huertas, Raul Ferrando Piqueres
Publikováno v:
European Journal of Hospital Pharmacy. 30:107-112
This study aimed to describe the actions taken to implement a telepharmacy programme with home medication dispensing and informed delivery in an outpatient pharmaceutical care unit of a tertiary hospital, where approximately 5000 patients are treated
Autor:
Antonio Solana-Altabella, Emilio Monte-Boquet, Marta Montero, Pablo Pérez-Huertas, Maria Jesús Cuéllar-Monreal, Miguel Salavert, José Luis Poveda-Andrés
Publikováno v:
Medicine. 101:e32208
Autor:
Pablo Pérez-Huertas, Asunción Albert-Marí, José María Fernández-Navarro, Eduardo López-Briz, Margarita Cueto-Sola, José Luis Poveda-Andrés, Paloma Escobar-Cava, Carmela Borrell-García
Publikováno v:
Europe PubMed Central
JOURNAL OF PEDIATRIC ONCOLOGY NURSING
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
JOURNAL OF PEDIATRIC ONCOLOGY NURSING
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Objective: To study the incidence, risk factors, and treatment of hemorrhagic cystitis secondary to BK-virus reactivation (HC-BKV) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the pediatric population. Methods: Case-control
Autor:
Pablo, Pérez Huertas, Margarita, Cueto Sola, Paloma, Escobar Cava, Carmela, Borrell García, Asunción, Albert Marí, Eduardo, López Briz, José Luis, Poveda Andrés
Publikováno v:
Farmacia Hospitalaria v.39 n.4 2015
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Farmacia Hospitalaria, Vol 39, Iss 4, Pp 210-216 (2015)
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Farmacia Hospitalaria, Vol 39, Iss 4, Pp 210-216 (2015)
The dosage of antineoplastic drugs has historically been based on individualized prescription and preparation according to body surface area or patient´s weight. Lack of resources and increased assistance workload in the areas where chemotherapy is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a779a6112e89e01c21ecb1386325d092
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432015000400004
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432015000400004
Autor:
Jesús, Ruiz Ramos, Margarita, Cueto-Sola, Ana, García Robles, Pablo, Pérez Huertas, María, Tordera Baviera, José Luis, Poveda Andrés
Publikováno v:
Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica. 26(86)
Pharmacogenetic studies have become in recent years a common practice in the development of new drugs, with the need to evaluate the information and readability of Informed Consent Forms(ICFs) to ensure compliance with the recommendations set by curr